Cosmo, EFG International, Sika, Swissquote: Swiss Equity Market Preview
The following companies’ shares may be active in Zurich. Stock symbols are in parentheses after company names. Prices are from the last close.
Cosmo Pharmaceuticals SpA (COPN SW): The Italian developer of treatments for digestive-tract infections said first-half revenue rose to 14.3 million euros ($18.7 million) while operating profit advanced to 2.1 million euros. The shares were unchanged at 16 Swiss francs.
EFG International AG (EFGN SW): The Swiss bank had its long-term issuer rating lowered to A3 from A2 by Moody’s Investors Service. The shares tumbled 6.8 percent to 11.7 francs.
Sika AG (SIK SW): Europe’s biggest maker of chemicals used in construction said first-half net income rose 63 percent to 150.5 million francs ($144.5 million). The shares rose 2 percent to 1,963 francs.
Swissquote Group Holding AG (SQN SW): Switzerland’s largest online broker said first-half net profit fell to 13.7 million francs from 15.9 million francs a year earlier because of higher costs. The company said it’s sticking to its full-year growth targets. The shares rose 0.5 percent to 44 francs.